Table 2.
Hospitalization cost per 250,000 live births
| Observed cost 10—21 years | Lifetime cost | |
|---|---|---|
| GW women overall | € 432,497 | € 2,772,884 |
| GW women not vaccinated | € 495,729 | € 2,836,116 |
| GW women vaccinated | € 190,464 | € 1,154,654* |
| Not vaccinated—Vaccinated | € 305,265 | € 1,681,462 |
| Observed cost 10—21 years | Lifetime cost | |
| CIN women overall | € 153,310 | € 5,311,117 |
| CIN women not vaccinated | € 173,414 | € 5,331,188 |
| CIN women vaccinated | € 60,197 | € 1,741,231* |
| Not vaccinated—Vaccinated | € 113,217 | € 3,589,957 |
| Observed cost 10—21 years | Lifetime cost | |
| GW/CIN women overall | € 585,807 | € 8,084,001 |
| GW/CIN women not vaccinated | € 669,143 | € 8,167,304 |
| GW/CIN women vaccinated | € 250,661 | € 2,895,885* |
| Not vaccinated—vaccinated | € 418,482 | € 5,271,419 |
GW genital warts, CIN cervical intraepithelial neoplasia, AC anal cancer, OC oropharyngeal cancer, GC genital cancer
*Assuming the same average risk reduction for all ages after 21 years